GELS

220.00% 1.98

Handel nachbörslich: 2.45 -0.43 -14.93%

Gelteq Ltd (GELS)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Gelteq Ltd Stock (GELS) Company Profile

Healthcare (1153)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GELS's Discussions on Twitter

Vergleichen Sie GELS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GELS Gelteq Ltd	2.88	8.78M	0	0	0	0.00
ZTS Zoetis Inc	149.99	66.56B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.33	45.76B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.45	45.66B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	14.00	16.04B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	292.82	12.79B	2.76B	1.11B	898.10M	22.77

Gelteq Ltd Aktie (GELS) Neueste Nachrichten

Finanzdaten der Gelteq Ltd-Aktie (GELS)

Es liegen keine Finanzdaten für Gelteq Ltd (GELS) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Gelteq Ltd (GELS)

Gelteq Ltd Stock (GELS) Company Profile

Vergleichen Sie GELS mit anderen Aktien

Gelteq Ltd Aktie (GELS) Neueste Nachrichten

Gelteq Ltd (GELS) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Dow Jumps Over 400 Points; Verizon Earnings Top Views - Benzinga

Sweetgreen Inc Inc. (SG) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Gelteq LimitedOrdinary Shares (NQ: GELS - FinancialContent

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Sometimes it’s not the drug, but how it’s delivered - Townsville Bulletin

Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga

Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India

Gelteq introduces SportsGel with China deal in H1 2025 By Investing.com - Investing.com South Africa

Gelteq's Strategic Move: New Sports Nutrition Brand Takes Aim at Asia's Fastest-Growing Market - Stock Titan

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Gelteq Appoints Matthew Jones as Head of Sports Performance - GlobeNewswire Inc.

Gelteq Taps UAE Football, Boston Celtics Nutrition Expert to Lead Sports Performance Division - StockTitan

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan

“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times

Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Gelteq CEO to Present at Benchmark's Discovery Investor Conference - StockTitan

The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl

Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead

NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal

Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal

The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal

Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal

Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn

Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World

Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World

Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan

Ins & OutsWeek Ending 11/15/2024 - substack.com

Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com

Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan

Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online

Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia

Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India

Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times

GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan

Argent Biopharma Lists New Shares on ASX - MSN

GELS Stock Price and Chart — NASDAQ:GELS - TradingView

Biotech company Gelteq prices IPO at $4 per share - MSN

Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN

Maas Group Reports Record Results and Growth Strategy - MSN

Qualitas Limited Releases 2024 Governance Statement - MSN

Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha

WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN

Finanzdaten der Gelteq Ltd-Aktie (GELS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie GELS